Impact of Prisma on Donor Site Pain
Impact of Promogran Prisma™ on Pain of Split-thickness Skin Graft Donor Sites Compared to Standard of Care Alone
Sponsor: NYU Langone Health
A NA clinical study on Donor Site Complication and Skin Graft Disorder, this trial is completed. The trial is conducted by NYU Langone Health and has accumulated 9 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2024 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Mar 2023 — May 2024 [monthly]
Recruiting NA
-
Jun 2022 — Mar 2023 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Sep 2021 — Jun 2022 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Sep 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- NYU Langone Health
For direct contact, visit the study record on ClinicalTrials.gov .